$ACHV some bears here are claiming they have no patent for their product, which is wrong. I asked the company about the issue some time ago and got these following answers. I think it's a paradigm changing product since it's clearly a better product than Champix. It's also approved in Europe. CPRX had a similar situation with a product already approved in Europe but which was already selling below counter in US for a fraction of the price they are asking but they seem to be doing fine now after the FDA approval. I think nothing rectifies the low market cap the market is giving ACHV for this great problem they are trying to solve but I might just be a fool..